The updated guidelines note that patients with stage IV NSCLC who have EGFR exon 19 deletions or exon 21 L858R substitutions can receive osimertinib plus platinum doublet chemotherapy or amivantamab ...
Department of Chemical and Process Engineering, University of Canterbury, Christchurch 8041, New Zealand ...
Thin Film and Nanoscience Laboratory, Department of Physics, Tripura University, Suryamaninagar, Agartala 799022, West Tripura, Tripura India ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback